Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Macrogenics (NQ: MGNX )

4.860 +0.240 (+5.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 388,057
Open 4.640
Bid (Size) 4.750 (2)
Ask (Size) 4.900 (5)
Prev. Close 4.620
Today's Range 4.630 - 4.870
52wk Range 2.130 - 7.900
Shares Outstanding 61,107,288
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MacroGenics (MGNX) Q1 2023 Earnings Call Transcript
MGNX earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Recap: Macrogenics Q1 Earnings
 
Via Benzinga

Performance

YTD
-23.58%
-23.58%
1 Month
-29.46%
-29.46%
3 Month
-19.93%
-19.93%
6 Month
-29.57%
-29.57%
1 Year
+47.27%
+47.27%

More News

Read More
Earnings Outlook For Macrogenics
Via Benzinga
MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About Macrogenics
Via Benzinga
Why MacroGenics Stock Tumbled Today
Via The Motley Fool
Macrogenics's Return On Capital Employed Insights
Via Benzinga
MacroGenics (MGNX) Q4 2022 Earnings Call Transcript
Via The Motley Fool
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
Via Benzinga
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)
From MacroGenics, Inc.
Via GlobeNewswire
Why MacroGenics Stock Inched Higher on Monday
Via The Motley Fool
Why Shares of MacroGenics Climbed Thursday
Via The Motley Fool
Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
Via Benzinga
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Shares of MacroGenics Jumped Thursday
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Earnings Scheduled For March 15, 2023
Via Benzinga
General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million
From MacroGenics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.